A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination with Dapagliflozin on CKD Progression in Participants with CKD and High Blood Pressure (AstraZeneca)

Protocol Name: A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination with Dapagliflozin on CKD Progression in Participants with CKD and High Blood Pressure

Sponsor: CKD & HTN

Indication: Alport Syndrome

Principal Investigator: Ankit Mehta, MD

Location: Landry Center, 411 N. Washington Ave, Suite #6000, Dallas, TX 75246

DETAILS >